PLATELET AND LIPOPROTEIN FUNCTION IN AFRICAN-AMERICANS
非裔美国人的血小板和脂蛋白功能
基本信息
- 批准号:6032130
- 负责人:
- 金额:$ 3.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-09-30 至 1999-08-31
- 项目状态:已结题
- 来源:
- 关键词:African American atherosclerosis blood lipoprotein blood vessel disorder calcium flux essential hypertension high density lipoproteins human tissue insulin sensitivity /resistance laboratory rabbit low angle X ray diffraction analysis low density lipoprotein platelet aggregation vascular smooth muscle
项目摘要
High blood pressure and vascular dysfunction strike African Americans with
greater frequency and severity than the American population in general,
and Caucasians in particular. Vascular disease, including hypertension
accounts for a disproportionately elevated morbidity and mortality in this
minority group. Why vascular disease is elevated in African Americans is
not clear and constitutes a primary objective of this proposal. Insulin
resistance (IR) has been identified as a factor cosegregating with
hypertension in African Americans. A strong correlation of IR with
borderline hypertension in African Americans has been documented,
suggesting that it may be causally related to the development of
hypertension in African Americans. There is evidence that IR contributes
not only to the etiology of hypertension, but also to obesity, non-insulin
dependent diabetes mellitus and atherogenic dyslipidemia. These four
conditions constitute the cardinal risk factors for the development of
atherosclerosis, the underlying disorder in myocardial infarction, stroke
and claudication, all of which are elevated in African Americans. Little
is known of the mechanistic basis by which IR contributes to hypertension
or vascular dysfunction in general. This study will focus on two principle
factors which are altered in IR and known to contribute to the overall
well being of the vasculature, circulating platelets and serum
lipoproteins. Preliminary data indicates that platelets from IR,
hypertensive African Americans have augmented Ca++ uptake and elevated
cytosolic Ca++ levels compared to control subjects. We also found elevated
cholesterol content of the platelet membrane, implicating abnormalities in
platelet membrane composition and structure with the altered Ca++
handling. The dyslipidemia of IR may mediate platelet and arterial smooth
muscle cell (SMC) membrane abnormalities and thus, cell function
abnormalities. We hypothesize that IR contributes to alterations in the
biological properties of circulating platelets and/or lipoproteins and
thereby contributes to the development of arterial disease, including
hypertension in African Americans and explains their elevated
cardiovascular risk. Accordingly, we will test: 1.) whether platelets from
IR, hypertensive African Americans display altered calcium handling,
membrane composition/structure and aggregatory activity; 2.), whether LDL
from IR, hypertensive African Americans can induce alterations in platelet
and human SMC function and/or alter Ca++ metabolism; and 3.) whether HDL
from IR, hypertensive African Americans can reverse atherosclerosis-
induced alterations in SMC function. This study will use freshly isolated
platelets and lipoproteins to study their mutual interactions and their
effects on human SMC cells in culture. Ca++ metabolism will be assessed
using 45Ca++ and Fura-2 techniques, and membrane structural parameters
assessed using x-ray diffraction techniques in an effort to shed light on
the role of altered platelets and lipoproteins in IR and its relationship
to cardiovascular risk in African Americans.
高血压和血管功能障碍困扰非裔美国人
比一般美国人更频繁、更严重,
尤其是白人。血管疾病,包括高血压
导致这一领域的发病率和死亡率不成比例地升高
少数群体。为什么非裔美国人的血管疾病发病率较高
尚不清楚,但构成了该提案的主要目标。胰岛素
电阻(IR)已被确定为与
非裔美国人的高血压。 IR 与 IR 有很强的相关性
非洲裔美国人的临界高血压已被记录,
表明这可能与疾病的发展存在因果关系
非裔美国人的高血压。有证据表明 IR 有助于
不仅与高血压的病因有关,而且与肥胖、非胰岛素有关
依赖性糖尿病和动脉粥样硬化性血脂异常。这四个
条件构成了发展的主要风险因素
动脉粥样硬化,心肌梗塞、中风的潜在疾病
和跛行,所有这些症状在非裔美国人中均较严重。小的
已知 IR 导致高血压的机制基础
或一般血管功能障碍。本研究将重点关注两个原则
IR 中发生变化且已知对整体影响的因素
脉管系统、循环血小板和血清的健康
脂蛋白。初步数据表明,来自 IR 的血小板,
高血压非裔美国人增加了 Ca++ 的吸收并升高
与对照受试者相比,细胞溶质 Ca++ 水平。我们还发现升高
血小板膜的胆固醇含量,暗示异常
Ca++ 改变后的血小板膜组成和结构
处理。 IR血脂异常可能介导血小板和动脉平滑肌
肌细胞 (SMC) 膜异常,从而影响细胞功能
异常。我们假设 IR 有助于改变
循环血小板和/或脂蛋白的生物学特性和
从而导致动脉疾病的发展,包括
非裔美国人的高血压并解释了他们的高血压
心血管风险。因此,我们将测试:1.) 血小板是否来自
红外线、高血压的非洲裔美国人表现出钙处理的改变,
膜组成/结构和聚集活性; 2.)、是否低密度脂蛋白
从IR来看,高血压的非洲裔美国人可以引起血小板的改变
和人类 SMC 功能和/或改变 Ca++ 代谢; 3.) 是否HDL
从IR来看,高血压的非洲裔美国人可以逆转动脉粥样硬化-
诱导 SMC 功能的改变。本研究将使用新鲜分离的
血小板和脂蛋白,研究它们之间的相互作用及其作用
对培养中的人类 SMC 细胞的影响。将评估 Ca++ 代谢
使用 45Ca++ 和 Fura-2 技术以及膜结构参数
使用 X 射线衍射技术进行评估,以期阐明
血小板和脂蛋白改变在 IR 中的作用及其关系
非洲裔美国人的心血管风险。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The smooth muscle cell membrane during atherogenesis: a potential target for amlodipine in atheroprotection.
动脉粥样硬化形成过程中的平滑肌细胞膜:氨氯地平预防动脉粥样硬化的潜在靶点。
- DOI:10.1067/mhj.2001.109947
- 发表时间:2001
- 期刊:
- 影响因子:4.8
- 作者:Tulenko,TN;Sumner,AE;Chen,M;Huang,Y;Laury-Kleintop,L;Ferdinand,FD
- 通讯作者:Ferdinand,FD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas N. Tulenko其他文献
Human Adult Stem Cells Restore Endothelial Migratory Dysfunction in a Hypoxic Environment
- DOI:
10.1016/j.jvs.2010.06.065 - 发表时间:
2010-09-01 - 期刊:
- 影响因子:
- 作者:
Sarah Fernandez;Rachel Song;Jason Comeau;Stephen McIlhenny;Hamid Abdollahi;Ping Zhang;Thomas N. Tulenko;Paul J. DiMuzio - 通讯作者:
Paul J. DiMuzio
Thomas N. Tulenko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas N. Tulenko', 18)}}的其他基金
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
- 批准号:
6045027 - 财政年份:2000
- 资助金额:
$ 3.29万 - 项目类别:
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
- 批准号:
6390953 - 财政年份:2000
- 资助金额:
$ 3.29万 - 项目类别:
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
- 批准号:
6537935 - 财政年份:2000
- 资助金额:
$ 3.29万 - 项目类别:
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
- 批准号:
6638725 - 财政年份:2000
- 资助金额:
$ 3.29万 - 项目类别:
SMOOTH MUSCLE CELL MEMBRANE DURING ATHEROGENESIS
动脉粥样硬化过程中的平滑肌细胞膜
- 批准号:
6684097 - 财政年份:2000
- 资助金额:
$ 3.29万 - 项目类别:
PLATELET AND LIPOPROTEIN FUNCTION IN AFRICAN-AMERICANS
非裔美国人的血小板和脂蛋白功能
- 批准号:
2228378 - 财政年份:1993
- 资助金额:
$ 3.29万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 3.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 3.29万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 3.29万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 3.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 3.29万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 3.29万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 3.29万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 3.29万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 3.29万 - 项目类别: